PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
New article from PharmaTox summarises the research on prenatal medication exposure and offspring epigenetic outcomes
June 22, 2021 8:38 PM
-
A new literature review on genetic teratology from PharmaTox and the Federal University of Rio Grande do Sul
June 8, 2021 12:00 AM
-
New International Partnerships for Excellent Education, Research and Innovation (INTPART) project funded !
May 14, 2021 11:28 AM
The project is called "International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)", and is led by Hedvig Nordeng, Department of Pharmacy.
-
PharmaTox yearly report 2020
Feb. 1, 2021 10:45 AM
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2020!
-
Emil Aas Stoltenberg will defend his PhD October 30th! Save the date!
Oct. 29, 2020 10:43 AM
Published Feb. 24, 2015 6:17 PM
- Last modified June 23, 2021 8:44 PM
